Dr Don Gerson | CEO
Pnuvax Inc

Dr Don Gerson, CEO, Pnuvax Inc

Dr. Gerson is currently President and CEO of both PnuVax, Inc. and PnuVax SL Biopharmaceuticals, Inc., developers and manufacturers of vaccines, located in Montreal. PnuVax, Inc. is dedicated to the development of low-cost vaccines for underserved populations worldwide and is the recipient of significant grant funding from the Bill and Melinda Gates Foundation.
Dr. Gerson received his PhD from McGill University, taught biophysics and biochemical engineering at the University of Western Ontario in Canada, and was a Member of the Basel Institute for Immunology at Hoffmann LaRoche in Switzerland, where he worked for Prof. Niels Jerne, winner of the Nobel Prize for Medicine in 1984.


DC Co-conference Day 2 April 4 @ 11:40

What can we learn from mAB bioprocessing to vaccines to make more vaccines? From R&D to full scale manufacturing and worldwide distribution

  • The transition from lab to manufacturing and large-scale production of low cost vaccines globally

back to speakers